Article

Evaluating the utility of REVEL and CADD for interpreting variants in amyotrophic lateral sclerosis genes

2023-08-08

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease affecting approximately two per 100,000 individuals globally. While there are many benefits to offering early genetic testing to people with ALS, this has also led to an increase in the yield of novel variants of uncertain significance in ALS-associated genes. Computational (in silico) predictors, including REVEL and CADD, are widely e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 997a7d1a-4d3c-532a-8e9e-e3cc1618d9d8
DOI: 10.1101/2023.08.03.23293616

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating the utility of REVEL and CADD for interpreting variants in amyotrophic lateral sclerosis genesDOI 10.1101/2023.08.03.23293616Read

Evaluating the Utility of REVEL and CADD for Interpreting Variants in Amyotrophic Lateral Sclerosis GenesSemantic proximity Read

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic VariantsSemantic proximity Read

High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.Semantic proximity Read

Incidence of amyotrophic lateral sclerosis-associated genetic variants: a clinic-based study.Semantic proximity Read

Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants.Semantic proximity Read

Credibility analysis of putative disease-causing genes using bioinformatics.Semantic proximity Read

REVEL Is Better at Predicting Pathogenicity of Loss-of-Function than Gain-of-Function VariantsSemantic proximity Read

REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variantsSemantic proximity Read

SOD-1 Variants in Amyotrophic Lateral Sclerosis: Systematic Re-Evaluation According to ACMG-AMP GuidelinesSemantic proximity Read

Clinical testing panels for ALS: global distribution, consistency, and challengesSemantic proximity Read

Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases.Semantic proximity Read

Characterizing proteomic and transcriptomic features of missense variants in amyotrophic lateral sclerosis genesSemantic proximity Read